Search

Issue
Title
Authors
A clinical case of treatment of recurrent inoperable locally advanced breast cancer using conformal radiotherapy. Case report
Medvedev S.V., Vlasova M.Y., Bolotina L.V., Kaprin A.D., Khmelevskiy E.V., Zikiryakhodzhaev A.D., Khakimova S.G., Khakimova G.G., Bychkova N.M., Zaitseva N.A., Abushova E.R., Guseva S.D., Maslov E.D.
A therapeutic-only versus prophylactic platelet transfusion strategy for preventing bleeding in patients with haematological disorders after myelosuppressive chemotherapy or stem cell transplantation (Russian Translation of Cochrane Plain Language Summary)
Zhilyakova V.V.
Chronic lymphocytic leukemia/small lymphocytic lymphoma
Nikitin E.A., Bialik T.E., Zaritskii A.I., Iseber L., Kaplanov K.D., Lopatkina T.N., Lugovskaia S.A., Mukhortova O.V., Osmanov E.A., Poddubnaya I.V., Samoilova O.S., Stadnik E.A., Falaleeva N.A., Baikov V.V., Kovrigina A.M., Nevol’skikh A.A., Ivanov S.A., Khailova Z.V., Gevorkian T.G.
Bevatsizumab v kombinatsii s khimioluchevoy terapiey u bol'nykh glioblastomoy
Smolin A.V., Konev A.V., Kobyakov G.L., Nikolaeva S.N., Shamanskaya Y.E., Gorbunov A.V.
CAR NK-сells for the treatment of hematological malignancies: A review
Gribkova I.V.
Experience of the usage intraoperative radiation therapy after neoadjuvant systemic drug treatment and sentinel lymph node biopsy in breast cancer patients with clinical stage T2N0M0
Manikhas A.G., Grinev I.A., Oganesian A.S., Chikrizov S.I., Manikhas G.M.
First results of the Russian multicenter epidemiology project on the malignant gliomas
Smolin A.V., Bekyashev A.H., Kobyakov G.L., Sharabura T.M., Mufazalov F.F., Kanischeva N.V., Bumagina V.O.
Nutritional support in the perioperative period of treatment of cancer patients: Retrospective cohort study
Gameeva E.V., Stepanovna A.M., Khoronenko V.E., Gridnev O.V., Sviridov S.V., Shestopalov A.E.
Lenvatinib as the key component of first-line therapy for patients with unresectable hepatocellular carcinoma
Bolotina L.V.
«Problema optimizatsii ad\"yuvantnoy endokrinnoy terapii na rannikh stadiyakh raka molochnoy zhelezy»
Semiglazov V.F., Poddubnaya I.V.
Personalized treatment options of refractory and relapsed medulloblastoma in children: literature review
Dinikina Y.V., Zheludkova O.G., Belogurova M.B., Spelnikov D.M., Osipov N.N., Nikitina I.L.
Modern perspectives in sequential therapy for metastatic colorectal cancer with reference to the use of regorafenib
Sekacheva M.I., Nuriev R.I., Rozhkov A.A., Semenkov A.V., Bagmet N.N., Boroda A.M.
Tsetuksimab v lechenii ryada solidnykh opukholey: dostizheniya i perspektivy
Besova N.S., Khokhlova S.V., Romanov I.S., Gorbunova V.A., Matyakin E.G.
Bevacizumab in advanced ovarian cancer: when, what for and why?
Tjulandina A.S.
Role of enzyme replacement therapy for exocrine and nutritional insufficiency in patients with malignancies: A review
Khatkov I.E., Maev I.V., Bordin D.S., Kononenko I.B., Kucheryavyy Y.A., Pokataev I.A., Snegovoy A.V., Tryakin A.A., Feoktistova P.S., Zhukova L.G.
Following in the footsteps of SABCS 2022: top 12 advanced breast cancer studies that could change our clinical practice: A review
Kolyadina I.V.
Supportive therapy for ovarian cancer
Pokataev I.A., Tyulyandin S.A.
Combined and complex treatment options for patients with operable rectal cancer
Barsukov Y.A., Tkachev S.I., Mamedli Z.Z., Kuzmichev D.V., Aliev В.А., Kim D.F.
Znachenie taksanov v neoad\"yuvantnoy terapii raka molochnoy zhelezy
Bozhok A.A., Semiglazov V.F., Kletsel' A.E., Arzumanov A.S., Ivanova O.A., Semiglazov V.V.
2024 events that may change the clinical practice for aggressive B-cell lymphomas in the future
Mangasarova Y.K., Zvonkov E.E.
Current approach to adjuvant therapy for breast cancer (a review)
Conte P., Guarneri V.
Novel therapeutic strategies for patients with metastatic triple-negative breast cancer
Ganshina I.P., Gordeeva O.O., Manukian M.S.
Adjuvant targeted therapy for non-small cell lung cancer
Laktionov K.K., Kazakov A.M., Gordiev M.G., Kononets P.V., Akhmedov B.B., Maevskaia J.N.
Comparative evaluation of the efficacy of an incomplete cytoreduction application in combination with systemic therapy and systemic therapy as mono-therapy in patients with metastatic clear-cell renal cell carcinomas
Borisov P.S., Orlova R.V., Shkolnik M.I., Karlov P.A.
New aspects of the first-line chemotherapy in colorectal cancer
Artamonova E.V.
Metronomic chemotherapy in pediatric neurooncology: insight the problem. A review
Dinikina Y.V., Zheludkova O.G., Ryzhova M.V., Olhova L.V., Korneev D.Y., Belogurova M.B.
Triple-negative breast cancer: new options for systemic targeted therapy. A review
Andreev D.A., Zavyalov A.A.
The first experience in Russia of applying a tumor differentiation protocol in a patient with progressive, radioiodine-refractory BRAF-positive papillary thyroid cancer. Case report
Slashchuk K.Y., Reinberg M.V., Serzhenko S.S., Sheremeta M.S., Nikiforovich P.A.
Hereditary forms of breast malignant neoplasms: prognosis, screening and prevention. A review
Sultanbaev A.V., Kolyadina I.V., Gilyazova I.R., Nasretdinov A.F., Musin S.I., Sultanbaeva N.I., Menshikov K.V.
Experience with the combination of tixagevimab + cilgavimab for pre-exposure prophylaxis of COVID-19 in cancer patients: A retrospective analysis
Lyadova M.A., Fedorinov D.S., Kuzmina E.S., Antonova T.G., Sokolskaya V.K.
Prospects for the treatment of neurofibromatosis type 1: A review
Mustafin R.N.
ELEVATE-RR – first head-to-head trial of acalabrutinib versus ibrutinib in previously treated high risk chronic lymphocytic leukemia
Bialik T.E., Vorob'ev V.I., Ionin V.A., Ysebaert L., Kaplanov K.D., Mendeleeva L.P., Nikitin E.A., Ptushkin V.V., Samoilova O.S., Stadnik E.A.
Treatment of metastatic hepatocellular carcinoma with lenvatinib. Case report and literature review
Menshikov K.V., Sultanbaev A.V., Akhmetgareeva K.T., Lipatov D.O.
Metastatic renal cell carcinoma of unknown primary site. Clinical follow-up
Ognerubov N.A., Antipova T.S., Gumareva G.E.
Treatment of children with medulloblastoma without metastatic involvement in the age group older than 3 years: international experience and results of intercenter trial
Levashov A.S., Zagidullina S.R., Stroganova A.M., Khochenkov D.A., Ryzhova M.V., Gorelyshev S.K., Kadirov S.U., Babelyan S.S., Grigorenko V.A., Sidel’nikov D.A., Subbotina N.N., Daylidite V.V., Mentkevich G.L.
Non-small cell lung cancer with the tracheal bifurcation involvement. Carinal pneumonectomy or chemo-radiation therapy?
Dadyev I.A., Davydov M.M., Shogenov M.S., Abdullaev A.G., Ibraev M.A., Filatov A.A.
Dural non-Hodgkin’s lymphomas
Babicheva L.G., Baikov V.V., Leenman E.E., Vinogradova Y.N., Ilyin N.V., Ryabchikova V.V., Poddubnaya I.V.
Modern possibilities of targeted therapy in metastatic colorectal cancer
Gorbunova V.A.
Russian multicenter retrospective study: preliminary data concerning clinical and molecular genetic characteristics in long-term responders to erlotinib
Smolin A.V., Gorbacheva A.V.
Clinical example of the drug pazopanib as a targeted therapy in inoperable cancer of the kidney
Klimenko A.A., Ivanov S.A.
Results of preoperative antitumor therapy in combination with bevacizumab and KRAS status during liver resections for colorectal cancer metastases
Sekacheva M.I., Bagmet N.N., Polishchuk L.O., Glazova O.V., Zaklyazminskaya E.V., Skripenko O.G.
Aromazin v ad\"yuvantnoy terapii raka molochnoy zhelezy
Artamonova E.V.
Vozmozhnosti ispol'zovaniya tsetuksimaba dlya lecheniya bol'nykh kolorektal'nym rakom
Orlova R.V., Tyukavina N.V.
8 let nadezhdy: novye dannye issledovaniya ATAS
Antiestrogennaya terapiya pri rake molochnoy zhelezy. Naskol'ko bezopasny ingibitory aromatazy?
Ptushkin V.V.
Limfoma Khodzhkina: prognosticheskie priznaki segodnya
Demina E.A.
Odnomomentnoe udalenie dvukh metastazov raka legkogo iz raznykh oblastey golovnogo mozga
Karakhan V.B., Aleshin V.A., Fu R.G., Krat V.B.
Experience of like-SJMB03 protocolin treatment of children with medulloblastomain the age group over 3 years:results of an intercenter pilot study
Levashov A. ., Zagidullina S.R., Valiev T.T., Stroganova A.M., Khochenkov D.A., Grigorenko V. ., Mikhaylova E.V., Tyurina E.V., Ryzhova M.V., Horielyshev S.K., Kadirov S.U., Polyakov V.G.
Radiation injuries of organs and tissues: mechanisms of occurrence, methods of prevention and treatment: A review
Balaeva D.A., Romanov D.S., Trofimova O.P., Gadzhibabaeva Z.Z., Gorchak Y.Y., Gariaev G.A.
The third-line therapy for patients with metastatic colorectal cancer: regorafenib or repeated administration of drugs? A review
Rykov I.V., Chubenko V.A.
Comparative analysis results of surgical treatment, chemoradiotherapy and chemotherapy with assessment of prognostic factors in cervical esophageal cancer
Radzhabova Z.A., Kotov M.A., Girshovich M.M., Ponomareva O.I., Tkachenko E.V., Mitrofanov A.S., Radzhabova M.A., Levchenko E.V.
Actual treatment options for locally advanced and metastatic cutaneous squamous cell carcinoma
Ignatova A.V.
ELEVATE-TN Study. New data of acalabrutinib in first-line treatment of chronic lymphocytic leukemia. Resolution
Poddubnaya I.V., Al-Radi L.S., Byalik T.E., Kaplanov K.D., Molostvova V.Z., Nikitin E.A., Pospelova T.I., Ptushkin V.V., Samoilova O.S., Stadnik E.A., Tumyan G.S.
Modern radiation therapy in part of treatment primary mediastinal (thymic) B-large cell lymphoma (results of 131 patients treated at N.N.Blokhin National Medical Research Center of Oncology of the Ministry of Health of the Russian Federation)
Trofimova O.P., Zavodnova I.Z., Tumyan G.S., Pryamikova Y.I., Volkova N.V., Zaichenko O.S., Nazarenko A.V.
The treatment of patients with advanced lung cancer associated with EGFR mutation
Bolotina L.V.
Features of surgical treatment of patients with breast cancer receiving preoperative systemic therapy
Kolyadina I.V., Poddubnaya I.V., Pavlikova O.A., Komov D.V.
The role and assessment of morphological regression after neoadjuvant therapy in breast cancer patients
Frank G.A., Ilatovskaia M.E., Andreeva I.I., Zavalishina L.E.
Keratoacanthoma: possible management approaches. Case reports
Teterin K.A., Kizhaev Y.E., Bolotova N.P.
Clinical cases of treatment of hepatocellular carcinoma
Lazarev S.A., Mamontov K.G., Manihas G.M., Antimonik N.Y.
RADIOTHERAPY AS THE ONLY TREATMENT IN CASE OF TONGUE CANCER PATIENTS
Garbuzov M.I.
The concept of resectability in the treatment of colorectal cancer liver metastases: the present notion
Bagmet N.N., Bedzhanyan A.L., Polishchuk L.O., Sekacheva M.I., Shatveryan G.A., Skipenko O.G.
Press-reliz Na XIII Rossiyskom kongresse onkologov obsudili sostoyanie epidemiologicheskoy programmy skrininga HER2-statusa u zhenshchin, bol'nykh rakom molochnoy zhelezy (RMZh), a takzhe preimushchestvai perspektivy targetnoy terapii preparatami Gertseptin i Avastin
Gormonal'naya terapiya raka predstatel'noy zhelezy. Otsenka effektivnosti neoad\"yuvantnoy terapii bikalutamidom i gozerelinom v techenie 3 i 6 mesyatsev pered radikal'noy prostatektomiey
Rasner P.I., Pushkar' D.Y., Govorov A.V.
Targetnaya terapiya raka pochki
Alekseev B.Y., Shegay P.V.
Lekarstvennaya terapiya solidnykh opukholey s metastazami v golovnom mozge
Konstantinova M.M.
Molekulyarno-biologicheskie faktory prognoza pri B-kletochnom khronicheskom limfoleykoze
Nikitin E.A., Malakho S.G., Biderman B.V., Poltaraus A.B., Sudarikov A.B.
The role of ESR1 gene mutation in therapy selection for HR+/HER2- metastatic breast cancer: A review
Paichadze A.A., Chashnikova E.P., Golubeva S.A.
Hyperbaric oxygen therapy for the treatment of the late effects of radiotherapy [Russian translation of the Plain Language Summary (PLS) of the Cochrane Systematic Review]
Yudina E.V.
Cabozantinib in the treatment of patients with advanced renal cell carcinoma
Volkova M.I., Turupaev K.A., Kalinin S.A.
The era of immuno-oncology in onco-urology: what have we achieved? The review of the symposium of the alliance between Merck and Pfizer held within the framework of the XXV Russian Oncology Congress. November 9, 2021
Editorial B.
Malignant neoplasms associated with HIV infection. Problems and solutions (problem outline)
Kaprin A.D., Voronin E.E., Rassokhin V.V., Rozenberg V.V., Nekrasova A.V., Falaleeva N.A., Ivanov S.A., Grivtsova L.Y.
Antiangiogenic therapy for breast cancer with triple negative phenotype
Ganshina I.P., Ivanova K.A., Gordeeva O.O., Arkhipov A.V., Zhukova L.G.
The role of second generation Bruton tyrosine kinase inhibitors in the treatment of chronic lymphocytic leukemia. Resolution
Poddubnaya I.V., Bialik T.E., Glonina N.N., Kalashnikova O.B., Kaplanov K.D., Lapin V.A., Medvedeva N.V., Mikhailova N.B., Moiseeva T.N., Nikitin E.A., Pospelova T.I., Stadnik E.A.
The first results of the national programme for the diagnosis and treatment of HER2-positive breast cancer in Turkmenistan
Berdimyradova M.B., Khadjiev S.M., Khommadova D.N., Polatova G.O., Kakajanova A.O., Batyrov C.B., Penayev D.N., Agayeva B.G., Annaberdiyeva G.A.
The comparative pharmacoeconomic analysis of tyrosine kinase inhibitor Iressa® (gefitinib) with TKI Giotrif® (afatinib) as first-line therapy for patients with advanced non-small cell lung cancer associated with mutations in the epidermal growth factor receptor
Ryazhenov V.V.
Klinicheskie sluchai lecheniya gepatotsellyulyarnogo raka v Rossii. Klinicheskiy sluchay 1 Bolee chem 3-letnyaya stabilizatsiya protsessa gepatotsellyulyarnogo raka na fone dlitel'nogo priema preparata sorafenib
Sheko S.S., Dem'yanova G.A.
The role of targeted therapy in the treatment of advanced hepatocellular carcinoma
Shakhnovich E.B., Kerbikov O.B., Kulaga E.A.
Modern options in personalized therapy of metastatic cutaneous melanoma
Protsenko S.A., Novik A.V., Akhaeva Z.Y., Zhabina A.S., Imyanitov E.N., Semenova A.I.
Algorithm of treatment of patients with castrate-resistant prostate cancer: modern concept and perspectives
Alekseev B.Y., Nyushko K.M., Kalpinskiy A.S., Kaprin A.D.
Retseptor faktora rosta fibroblastov 1-go tipa kak mishen' tselenapravlennoy terapii pochechno-kletochnogo raka
Timofeev I.V.
Efficiency of radiotherapy for cancer of the vermilion border of lower lip in terms of balance between quantitative and qualitative results
Garbuzov M.I.
Ad\"yuvantnaya terapiyav lechenii gastrointestinal'nykh stromal'nykh opukholey
Nikulin M.P., Stilidi I.S.
Ingibitory vnutrikletochnoy peredachi signala pri melanome: perspektivy i razocharovaniya targetnoy terapii
Konstantinova M.M.
Znachenie luchevoy terapii v lechenii generalizovannykh nekhodzhkinskikh limfom (IV stadiya)
Kharchenko V.P., Pan'shin G.A., Sotnikov V.M., Datsenko P.V., Smol'tsova N.N., Nikolaeva E.V.
Nekhodzhkinskie limfomy mochepolovoy sistemy
Bogdanov A.N., Maksimov A.G., Anosov N.A., Krivolapov Y.A.
Opyt primeneniya Regional'noy programmy v g. Krasnodare
Mitashok I.S.
New therapies for hormone-positive HER2-negative metastatic breast cancer with AKT signaling alterations: the Expert Panel Decision
Editorial B.
How a significant increase in survival in pancreatic cancer is achieved. The role of nutritional status and supportive care: A review
Zhukova L.G., Bordin D.S., Dubtsova E.A., Ilin M.A., Kiriukova M.A., Feoktistova P.S., Egorov V.I.
Can musical interventions benefit patients with cancer?
Razumovskaya E.A.
The effect of antioxidant drugs on the self-assessment of clinical symptoms in women during radiation therapy after surgical treatment of endometrial cancer: Placebo-controlled randomized trial
Volchegorskii I.A., Vazhenin A.V., Alekseeva A.P.
Metastatic cervical cancer: clinical experience with pembrolizumab application. Case report
Protasova A.E., Strakh L.V., Lando E.I., Sidorkina E.V.
Systemic treatments for metastatic cutaneous melanoma (Russian Translation of Cochrane Plain Language Summary – PLS)
Ziganshin A.U.
Prospects for the development of adjuvant therapy for non-small cell lung cancer
Laktionov K.K., Kazakov A.M., Reutova E.V., Ardzinba M.S., Arzumanian A.L.
Modern immunological criteria for a stratification of risk groups for precursor B cell acute lymphoblastic leukemia in children
Shervashidze M.A., Valiev T.T., Batmanova N.A., Tupitsyn N.N., Serebryakova I.N.
Dermatomyositis and polymyositis in breast cancer patients: a case reports
Ganshina I.P., Zhukova L.G., Burnevitch E.Z., Gordeeva O.O., Kondratieva O.E.
Predictive factors of achievement pathological complete response at neoadjuvant chemotherapy of primary operable breast cancer
Pavlikova O.A., Kolyadina I.V., Komov D.V., Vishnevskaya Y.V., Poddubnaya I.V.
The optimization of second-line therapy for metastatic colorectal cancer: new targeted therapy options
Artamonova E.V., Manzyuk L.V.
Radiation-induced lung injury in breast cancer patients after breast conservation therapy
Trofimova O.P., Tkachev S.I., Ivanov S.M., Utkina V.L., Cheban O.I., Glebovskaya V.V.
Angiogenesis as a target for cancer therapy
Imyanitov E.N.
The main markers of the long-term efficiency of neoadjuvant chemotherapy in breast cancer (review of literature)
Semiglazov V.F., Semiglazov V.V., Paltuev P.M., Nikolaev K.S., Dashyan G.A.
1 - 100 of 185 Items 1 2 > >> 

Search tips:

  • Search terms are case-insensitive
  • Common words are ignored
  • By default only articles containing all terms in the query are returned (i.e., AND is implied)
  • Combine multiple words with OR to find articles containing either term; e.g., education OR research
  • Use parentheses to create more complex queries; e.g., archive ((journal OR conference) NOT theses)
  • Search for an exact phrase by putting it in quotes; e.g., "open access publishing"
  • Exclude a word by prefixing it with - or NOT; e.g. online -politics or online NOT politics
  • Use * in a term as a wildcard to match any sequence of characters; e.g., soci* morality would match documents containing "sociological" or "societal"